#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4000295	Functional	Inhibition of luciferase expression in human HT1080 cells after 24 hrs	Homo sapiens	1	ALA4000145	cell-based format	Scientific Literature
2.	ALA4000296	Binding	Inhibition of porcupine (unknown origin) expressed in HEK293-STF3A cells assessed as inhibition of Wnt signaling by measuring decrease in beta-catenin-mediated transcriptional activity after 24 hrs by Steady-Glo luciferase assay	Homo sapiens	16	ALA4000145	cell-based format	Scientific Literature
3.	ALA4000299	Physicochemical	Thermodynamic solubility of the compound at pH 7.4		4	ALA4000145	small-molecule physicochemical format	Scientific Literature
4.	ALA4000300	Physicochemical	Permeability of the compound at pH 7.4 by PAMPA assay		4	ALA4000145	small-molecule physicochemical format	Scientific Literature
5.	ALA4000301	ADME	Inhibition of CYP3A4 (unknown origin)	Homo sapiens	9	ALA4000145	single protein format	Scientific Literature
6.	ALA4000302	ADME	Inhibition of CYP2D6 (unknown origin)	Homo sapiens	9	ALA4000145	single protein format	Scientific Literature
7.	ALA4000304	ADME	Intrinsic clearance in mouse liver microsomes	Mus musculus	11	ALA4000145	assay format	Scientific Literature
8.	ALA4000305	Binding	Inhibition of PORCN-mediated V5-tagged Wnt3A palmitoylation in human HeLa cells at 100 nM measured after over night incubation by Western blot analysis	Homo sapiens	3	ALA4000145	cell-based format	Scientific Literature
9.	ALA4000306	Binding	Inhibition of mouse PORCN expressed in human HT1080 cells coexpressing Wnt/beta-catenin assessed as decrease in beta-catenin-mediated transcriptional activity at 0.2 to 625 nM after 24 hrs in presence of Wnt3a by luciferase reporter gene assay	Mus musculus	1	ALA4000145	cell-based format	Scientific Literature
10.	ALA4000307	Functional	Antitumor activity in Balb/c mouse MMTV-Wnt1 model assessed as tumor growth inhibition at 1 mg/kg administered once daily for 14 days via oral gavage relative to vehicle treated control	Mus musculus	1	ALA4000145	organism-based format	Scientific Literature
11.	ALA4000308	Functional	Antitumor activity in Balb/c mouse MMTV-Wnt1 model assessed as tumor growth inhibition at 3 mg/kg administered once daily for 14 days via oral gavage relative to vehicle treated control	Mus musculus	1	ALA4000145	organism-based format	Scientific Literature
12.	ALA4000309	Functional	Antitumor activity in Balb/c mouse MMTV-Wnt1 model assessed as tumor growth inhibition at 10 mg/kg administered once daily for 14 days via oral gavage relative to vehicle treated control	Mus musculus	1	ALA4000145	organism-based format	Scientific Literature
13.	ALA4000310	Functional	Antitumor activity in Balb/c mouse MMTV-Wnt1 model assessed as tumor growth inhibition administered once daily for 14 days via oral gavage	Mus musculus	1	ALA4000145	assay format	Scientific Literature
14.	ALA4000311	ADME	Oral bioavailability in mouse at 5 mg/kg	Mus musculus	1	ALA4000145	organism-based format	Scientific Literature
15.	ALA4000312	ADME	Cmax in mouse at 5 mg/kg, po	Mus musculus	1	ALA4000145	organism-based format	Scientific Literature
16.	ALA4000313	ADME	Half life in mouse at 1 mg/kg, iv	Mus musculus	1	ALA4000145	organism-based format	Scientific Literature
17.	ALA4000314	ADME	AUC (0 to last) in mouse at 5 mg/kg, po	Mus musculus	1	ALA4000145	organism-based format	Scientific Literature
18.	ALA5227328	Binding	Inhibition of mouse STF3A	Mus musculus	5	ALA5226302	single protein format	Scientific Literature
19.	ALA5227329	Physicochemical	Solubility of the compound at pH 7.4		4	ALA5226302	small-molecule physicochemical format	Scientific Literature
20.	ALA5227331	ADME	Oral bioavailability in mouse at 2.5 mg/kg	Mus musculus	3	ALA5226302	organism-based format	Scientific Literature